Non-small cell lung cancer: radiation therapy for locoregional recurrence after complete resection

Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma

Hiroshi Onishi, Tsutomu Araki, Hiroki Shirato et al. · Cancer · 2004 · 902 citations · Full text

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11.

James D. Cox, N. Azarnia, Roger W. Byhardt et al. · Journal of Clinical Oncology · 1990 · 471 citations

Surgical Oncology, Treatment Verification, Radiation Medicine +19

Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies.

Ronald Feld, Larry Rubinstein, T H Weisenberger · Journal of Clinical Oncology · 1984 · 318 citations

Surgical Oncology, Pathology, First Relapse +16

The impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer

L. Vanuytsel, Johan Vansteenkiste, Sigrid Stroobants et al. · Radiotherapy and Oncology · 2000 · 284 citations

Positron Emission Tomography, Nuclear Medicine, Oncologic Imaging +9

Cancer recurrence after resection: T1 N0 non-small cell lung cancer

Paul Thomas · The Annals of Thoracic Surgery · 1990 · 227 citations

Surgical Oncology, Medicine, Cancer Recurrence +6